mdr1及P-gP与脑胶质瘤耐药关系的研究
被引量:1
摘要
恶性胶质瘤患者平均生存期较短,通常手术切除肿瘤组织并不能从根本上延长患者的生存时间,而且应用药物化疗易产生多药耐药性(multidrug resistance,MDR),使化疗失败。P-糖蛋白(P-glycoprotein,P-gp)和多药耐药相关蛋白(multidrug resistance associated protein,MRP)介导的药物外排是产生MDR的主要机制,其编码基因分别为mdr1和 mrp1。
出处
《天津医药》
CAS
北大核心
2011年第2期169-170,共2页
Tianjin Medical Journal
参考文献6
-
1刘福生,张庆林,赵丽,卞继峰,庞琦,王成伟.胶质瘤多药耐药细胞系C_6/adr的建立及其生物学特性的研究[J].中华神经外科杂志,2001,17(2):109-112. 被引量:10
-
2于如同,陈冲,石琼,刘明峰,饶海承.MDR1 shRNA对人脑胶质瘤干细胞多药耐药性实验研究[J].中华神经外科疾病研究杂志,2008,7(6):494-497. 被引量:4
-
3潘强,杨学军.胶质瘤化疗药物耐药性分子机制的研究进展[J].中国临床神经外科杂志,2010,15(2):118-122. 被引量:5
-
4王翔,游潮.胶质瘤化疗耐药机制研究进展[J].华西医学,2008,23(6):1495-1496. 被引量:2
-
5Decleves X,Fajac A,Lehmann-Che J,et al.Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines[J].Int J Cancer,2002,98(2):173-180.
-
6Triller N,Korosec P,Kern I,et al.Multidrug resistance in small cell lung cancer:expression of P-glycoprotein,multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease[J].Lung Cancer,2006,54(2):235-240.
二级参考文献46
-
1Labialle S, GayetL, Marthinet E, et al. Transcriptional regulators of the human muhidrug resistance 1 gene: recent views [ J ]. Biochem Pharmacol, 2002, 64 ( 5 - 6 ) : 943 - 948.
-
2Comerford KM, Wallace TJ, Karhausen J, et al. Hypoxia-inducible factor-1 - dependent regulation of the muhidrug resistance ( MDR1 ) gene [J]. Cancer Res, 2002, 62( 12): 3387-3394.
-
3Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumor [ J]. Cancer Res, 2003, 63 (18) : 5821 - 5828.
-
4Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma [ J ]. Cancer Res, 2004, 64( 19): 7011 -7021.
-
5Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors [ J]. Proc Natl Acad Sci USA, 2003, 100(25) : 15178 -15183.
-
6Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi) [J]. FEBSLett, 2003, 545(2-3): 144 -150.
-
7Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells [ J]. Science, 2002, 296(5567) : 550-553.
-
8Paus C, Murat A, Stupp R, et al. Role of MGMT and clinical applications in brain tumors [J]. J Bull Cancer, 2007, 94(9): 769-773.
-
9Ostrowski IrE, von Wronski MA, Bigner SH, et al. Expression of 06-methylguanine-DNA methyltransferase in malignant human glioma cell lines [J]. Carcinogenesis, 1991, 12 (9): 1739-1744.
-
10Hegi ME, Liu L, Herman JG, et al. Correlation of O6-methylguanine methyhransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity [J]. J Clin Oneol, 2008, 26 (25): 4189-4199.
共引文献17
-
1张健,张庆林,王成伟,孔建新,郭华,刘福生,陶荣杰,马道新.反义寡核苷酸抑制大鼠胶质瘤多药耐药细胞株中Pgp相关基因表达的实验研究[J].中华神经外科杂志,2004,20(5):353-356.
-
2郭华,张庆林,王成伟,张健,孔建新,刘福生,马道新,卞继峰.反义肽核酸逆转人神经母细胞瘤多药耐药性的实验研究[J].中华神经外科杂志,2005,21(2):113-117.
-
3孔建新,宋千,刘延鹏,王成伟,张庆林.反义寡聚脱氧核苷酸抑制脑胶质瘤多药耐药基因1的表达[J].中国医学科学院学报,2005,27(2):211-215.
-
4郭华,张庆林,张健,王成伟,孔建新,刘福生,马道新,卞继峰.反义肽核酸阻断人神经母细胞瘤多药耐药相关蛋白P-糖蛋白的表达[J].中国医学科学院学报,2005,27(3):300-304. 被引量:4
-
5王成伟,马道新,潘顺,宋千,王志刚,张庆林.C6胶质瘤细胞多药耐药基因启动子靶向的双自杀基因表达载体的构建及鉴定[J].中华神经外科杂志,2005,21(11):691-694. 被引量:6
-
6郑文斌,王春晖,强鸥,唐承薇.美洛昔康不诱导胃癌细胞耐药[J].中国药理学通报,2006,22(1):39-43. 被引量:3
-
7王成伟,马道新,王志刚,潘顺,宋千,张庆林.MDR1启动子控制双自杀基因系统的建立及其在耐药胶质瘤细胞中特异性表达的初步研究[J].中华神经外科杂志,2007,23(9):681-684. 被引量:2
-
8王波,王志云,王成伟,王志刚,张源,张庆林.MDR1启动子调控的双自杀基因靶向杀伤耐药胶质瘤细胞的研究[J].山东大学学报(医学版),2008,46(1):15-18. 被引量:1
-
9丁建波,秦智勇.神经胶质瘤的基因治疗[J].国际神经病学神经外科学杂志,2010,37(5):418-422. 被引量:4
-
10张所军,万锋,郭东生,雷霆.神经球培养方法在脑肿瘤干细胞研究中的应用及其局限性[J].中华神经外科杂志,2011,27(3):316-319.
同被引文献16
-
1Andratachke N, Grosu AL, Molls M, et al. Perspectives in the treatment of malignant gliomas in adults [J]. Anticancer Res, 2001, 21(5): 3541-3550.
-
2Cianfriglia M. The biology of MDR1-P-glycoprotein (MDR1-Pgp) in designing functional antibody drug conjugates (ADCs): the experience ofgemtuzumab ozogamicin [J]. Ann Ist Super Sanita, 2013, 49(2): 150-168. DO1:10.4415/ANN 13 02 07.
-
3Dean M, Fojo T, Bates S. Tumor stem cells and drug resistance[J]. Nat Rev Cancer, 2005, 5(4): 275-284. DO1:10.1038/nrc1590.
-
4Higgins CF. Multiple molecular mechanisms for multidrug resistance transporters [J]. Nature, 2007, 446: 749-757. DOI: 10.1038/nature05630.
-
5Debska S, Owecka A, Czernek U, et al. Transmembrane transporters ABCC-structure, function and role in muhidrug resistance of cancer cells [J]. Postepy I-lig Med Dosw (Online), 2011, 65: 552-561. DOI: 10.5604/17322693.956500.
-
6Remer S, Murphy ME. The challenges of long-term treatment outcomes in adults with malignant gliomas [J]. Clio J Oncol Nuts, 2004, 8(4): 368-376, DOI: 10.1188/04.CJON.368-376.
-
7Nakagawa T, Ido K, Sakuma T, et al. Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas [J]. Neuropathology, 2009, 29 (4): 379-388. DOI: 10.111 i/j.1440-1789.2008.00983.x.
-
8Krishnamachary N, Center MS. The MRP gene associated with a non-pglycoprotein multidrug resistance encodes a 190-KDa membrane bound glycoprotein [J]. Cancer Res, 1993, 53 (7): 3658-3662.
-
9Bader P, Schilling F, Schlaud M, et al. Expression analysis of multidrug resistance associateed genes in neuroblastomas[J]. Oncol Rep, 1999, 6(5): 1143. DOI: 10.3892/or.6.5.1143.
-
10Faria GP, O liveira JA, O liveira JG, et al. Differences in the expression pattern of P-glycoprotein and MRP1 in low-grade and high-grade gliomas[J]. Cancer Invest, 2008, 26(9): 883-889. DOI: 10.1080/07357900801975264.
引证文献1
-
1黄从刚,段发亮,陈谦学,吴京雷,黄乔春,陈晓斌,闵强,罗明,李乾锋,宋平.X线照射后耐替莫唑胺U251细胞株中多药耐药基因MDR1及P-gp蛋白的表达[J].中华神经医学杂志,2016,15(1):60-64. 被引量:4
二级引证文献4
-
1王岩,郑克彬,史彦芳.CREB参与胶质瘤细胞多药耐药分子机制的研究[J].医学研究与教育,2017,34(2):1-10. 被引量:1
-
2侯亮,冯海利.脑胶质瘤组织中P-gp、MRP、BCRP的表达及临床意义[J].中国医药导报,2017,14(35):12-15. 被引量:6
-
3侯亮,冯海利,张培胜.脑胶质瘤组织中P糖蛋白及多药耐药相关蛋白的表达及临床意义[J].中国肿瘤临床与康复,2018,25(4):390-393. 被引量:3
-
4黄从刚,罗明,陈谦学,王远,黄乔春,周洁,王兴弯,罗志华,段发亮.转录因子E2F1过表达对脑胶质瘤U251细胞辐射敏感性的影响[J].中华行为医学与脑科学杂志,2023,32(3):218-224. 被引量:1
-
1谢玲玲,景蓉蓉,卢美红,鞠少卿.耐药miRNA与血液系统恶性肿瘤[J].临床检验杂志,2013,31(3):204-207. 被引量:2
-
2朱莉,张丽,李光耀,王美芝,马霖,陈雪红,王春波.复发及难治急性髓细胞白血病病人多药耐药基因检测及意义[J].青岛大学医学院学报,2007,43(6):471-472.
-
3张咏梅,王朝卿,孙建锁,宋光耀.非小细胞肺癌组织中MRP1 mRNA和GST-π mRNA的表达及意义[J].中华肿瘤防治杂志,2007,14(12):913-916. 被引量:9
-
4邵松军,张湘宁,黄培春.多药耐药基因及相关耐药蛋白在肿瘤中的研究进展[J].国际肿瘤学杂志,2013,40(7):494-497.
-
5刘尚国,沈祖楹,于扬.结肠癌中多药耐药相关蛋白和肺耐药蛋白的表达[J].贵阳医学院学报,2003,28(5):393-395. 被引量:7
-
6朱士娜,刘晖,王秋芳,戴红英.卵巢上皮癌组织TLR4和P-gp表达及其临床意义[J].齐鲁医学杂志,2012,27(4):295-298. 被引量:2
-
7邢立娟,杨娜,袁慧云.MRP在急性白血病及MDS患者骨髓涂片中的表达及预后分析[J].中国误诊学杂志,2010,10(19):4603-4603. 被引量:1
-
8刘伟,安杰,侯会池.胆管癌耐药相关蛋白LRP和P170的表达及临床意义[J].中国现代普通外科进展,2010,13(9):676-678. 被引量:1
-
9张馨,毛大华,邓英蕾.多药耐药相关蛋白、P53蛋白在乳腺癌中的表达[J].贵阳医学院学报,2014,39(3):336-339. 被引量:3
-
10焦洁(综述),吕卫国(审校),谢幸(审校).卵巢癌肿瘤干细胞的研究进展[J].国际肿瘤学杂志,2010,37(2):150-152.